Immunoassay Analyzers Market Trends

The global immunoassay analyzers market size was valued at USD 7.61 billion in 2023 and is projected to grow at a CAGR of 3.2% from 2024 to 2030. An increase in incidences of chronic diseases, such as infectious and noninfectious diseases, is the primary factor driving the market growth. Technological innovations and applications of immunoassay are rapidly expanding due to diseases such as cancer and cardiology.

The rise in the number of chronic and infectious diseases is a leading cause of market growth for immunoassay analyzers. The rising number of cardiology and cancer cases is contributing to the development of new and advanced treatment options, and companies are innovating new treatments. The WHO reported 20 million new cases of cancer in 2022 and has projected the estimated number of cancer diagnoses to 53.5 million.

Gather more insights about the market drivers, restrains and growth of the Immunoassay Analyzers market

During the outbreak of the COVID-19 pandemic, the SARS-CoV-2 virus created an urgent need for an accelerated diagnosis, promising precision and affordability combined in one method. RT-PCR tests were conducted for early diagnosis but were considered an expensive approach. That drove immunoassay analyzers to be deployed to detect antibodies for quick and cost-effective methods. For instance, Agilent Technologies, Inc. launched Agilent Dako SARS-CoV-2, an enzyme-linked immunoassay kit to detect SARS-CoV-2 antibodies in human serum or plasma. The pandemic brought awareness of immunoassay analyzers in the market and accelerated technological developments.

The rise in chronic diseases has led to technological advancements in immunoassay analyzers. Emerging diseases, antibiotic resistance, and the demand for personalized medicine drive the advancements of sensitive, specific, and rapid immunoassay tests. Various companies are coming up with technological solutions to fulfill this demand for treatment. For instance, Diamond Diagnostics is ensuring healthcare providers access to advanced immunoassay diagnostics through the manufacturing of high-quality and cost-effective consumables and accessories products of immunoassay analyzers. Such innovations are expected to drive market growth.

The rise in collaboration activities of various companies is another driving factor for market growth. For instance, Beckman Coulter, Inc. and Fujirebio partnered in July 2023 to strengthen respective immunoassay capabilities to support therapeutic advancement, clinical trials, routine clinical adoption, and reimbursement in neurodegenerative diseases. Such partnerships are driving the market growth of immunoassay analyzers.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Patient Handling Equipment Market Size, Share & Trends Analysis Report By Type (Wheelchairs, Medical Lifting Slings), By Application (Bariatric Care, Long Term Care), By End Use, By Region, And Segment Forecasts, 2024 - 2030
• Cardiac Safety Services Market Size, Share & Trends Analysis Report By Service (ECG/Holter Monitors, Blood Pressure Monitors), By Type (Integrated), By End-use, By Region and Segment Forecasts, 2024 - 2030

Recent Developments

• Fujirebio and Agappe entered a business collaboration in January 2024 in the field of CLIA-based immunoassay, aiming to accelerate the Contract Development and Manufacturing Organization (CDMO) strategy.
• Siemens Healthineers launched the Atellica CI Analyzer for immunoassay and clinical chemistry testing in July 2023.
• DiaSorin S.p.A launched LIAISON legionella urinary assay in July 2023 accepting CE Mark to improve the legionnaires’ disease diagnosis.

Key Companies profiled:

Some prominent players in the global immunoassay analyzers market include

• Siemens Healthineers AG
• BIOMÉRIEUX
• Abbott
• QuidelOrtho Corporation
• Sysmex Corporation
• BD
• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche Ltd
• Beckman Coulter, Inc.
• DiaSorin S.p.A.

Order a free sample PDF of the Immunoassay Analyzers Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

Explore Horizon, the world's most expansive market research database